AA

Alaa Ayad Abdulrazzaq Alsaleh

Active Director Director DIN 07555590
DIN 07555590 First appointment Aug 2016 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Alaa Ayad Abdulrazzaq Alsaleh

Data last updated:

Alaa Ayad Abdulrazzaq Alsaleh is a Director at Meroven Pharma India Private Limited (since 2016). The company operates in Pharma.

DIN 07555590
Primary Designation Director
Industry Pharma
First Appointment 08 Aug 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Meroven Pharma India Private Limited U24299DL2016FTC304106
Director08 Aug 20162016Active

Board colleagues of Alaa Ayad Abdulrazzaq Alsaleh

Directorship timeline

Open interactive timeline →
Meroven Pharma India Private Limited
Premium access

Shareholding and investment profile for Alaa Ayad Abdulrazzaq Alsaleh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alaa Ayad Abdulrazzaq Alsaleh

Alaa Ayad Abdulrazzaq Alsaleh currently holds 1 directorship: Meroven Pharma India Private Limited (Director, since 08 Aug 2016).

Alaa Ayad Abdulrazzaq Alsaleh was first appointed on 08 Aug 2016 as Director at Meroven Pharma India Private Limited.

The current boards of Alaa Ayad Abdulrazzaq Alsaleh's companies include Abdalla Rafik Darvesh (Meroven Pharma India Private Limited), Eyad A S A Alsaleh (Meroven Pharma India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available